Scotiabank Sticks to Its Buy Rating for Inmune Bio (INMB)
In a report released today, George Farmer from Scotiabank maintained a Buy rating on Inmune Bio (INMB – Research Report), with a price target ...
Yahoo Finance3d
Biomea Fusion to Become a Diabetes & Obesity Medicines Company
REDWOOD CITY, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical ...